5 mu g/mL/>0.5 mu g/mL). CA ranged from 93.6% (caspofungin) to 99.6% (micafungin)

with less than 1% very major or major errors. The YeastOne colorimetric method remains comparable to the CLSI BMD reference method for testing the susceptibility of Candida spp. to the echinocandins when using the new (lower) CBPs and ECVs. Further study using define fks mutant strains of Candida is warranted. (c) 2012 Elsevier Inc. All rights reserved.”
“Background: Primary small cell carcinoma of the upper urinary tract (UUT-SCC) is an CBL0137 purchase extremely uncommon disease. The current knowledge of these rare tumors is mainly based on case reports or small series. Methods: We reported two cases and performed a systematic literature search from 1970 to 2010 for articles on Sirtuin inhibitor UUT-SCC. Overall, 40 patients with UUT-SCC were reviewed, a database was generated to analyze clinical characteristics, pathological features and therapy outcomes and to attempt in identifying prognostic factors.\n\nResults: For the 39 cases with available data, median age was 66.5 years and male-female ratio was 2:1. An Asian ethnic background

was more common (59%). Surgery was the standard treatment given to all patients. In 67% of cases, SCC coexisted with another malignant component, including urothelial carcinoma in 62% of patients. Overall median survival was 15

months and the 1-, 2- and 3-year survival rates were 58.4%, 38.1% and 23.8%, respectively. Of all cases, 53.8% developed detectable metastasis in a median delay of 13 months. Pathological stage was the only significant prognostic factor found (p = 0.01). Patients who received adjuvant chemotherapy seem to have a higher median survival comparatively to those who did not receive chemotherapy but this was not statistically significant (24 vs. 12 months, p = 0.56).\n\nConclusions: UUT-SCC is an extremely rare tumor characterized Luminespib in vivo by an aggressive clinical course. Local or distant metastases are frequent and survival is poor. Pathological stage appeared to be a prognostic factor for overall survival. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.”
“OBJECTIVE: To analyze flows of travel between place of residence and health care services by children and adolescents with cancer.\n\nMETHODS: The flows of travel between place of residence and the health care service for children and adolescents receiving care in Brazil’s Unified Health System (SUS) were monitored between 2000 and 2007. The unit of analysis was the health care district. The geographical information system data and network methodology, by type of treatment received (chemotherapy and radiotherapy) and hospital admissions were used.